Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Biofrontera AG - Filing #6520750

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Das sonstige Ergebnis nach Steuern enthält lediglich Umrechnungsdifferenzen aus der Umrechnung des Geschäftsbetriebs in Fremdwährung in die Konzernwährung.
Description of functional currency
Der Konzernabschluss zum 31. Dezember 2023 wird in EUR (bzw. TEUR), der funktionalen Währung der deutschen in den Konzernabschluss einbezogenen Unternehmen, und der Darstellungswährung des Konzerns, aufgestellt.
Description of presentation currency
EUR
Reserve of exchange differences on translation
1,000 EUR
0 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
13,012 EUR
17,669 EUR
Current assets
17,720 EUR
15,056 EUR
Non-current liabilities
678,000 EUR
4,002 EUR
Current liabilities
10,073 EUR
8,387 EUR
Revenue
32,249 EUR
25,738 EUR
Profit (loss)
0 EUR
369,000 EUR
0 EUR
369,000 EUR
0 EUR
44,166 EUR
44,166 EUR
0 EUR
0 EUR
Other comprehensive income
0 EUR
1,000 EUR
0 EUR
0 EUR
1,000 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
Comprehensive income
0 EUR
368,000 EUR
0 EUR
369,000 EUR
1,000 EUR
0 EUR
44,166 EUR
44,166 EUR
0 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.